Keywords: poland, place, pharmaceutical, investments, capgemini, report, suggests

Poland is not the place for pharmaceutical investments, Capgemini report suggests

Article | 12 July 2004

Print This

The entry of US generic drugmaker IVAX onto the Polish market, via itsacquisition of shares in drugmaker Polfa Kutno (Marketletter ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in